about
Protein Phosphatase 2A as a Therapeutic Target in Acute Myeloid LeukemiaLinking Pesticide Exposure with Pediatric Leukemia: Potential Underlying MechanismsIncreasing TIMP3 expression by hypomethylating agents diminishes soluble MICA, MICB and ULBP2 shedding in acute myeloid leukemia, facilitating NK cell-mediated immune recognitionHigher expression levels of the HOXA9 gene, closely associated with MLL-PTD and EZH2 mutations, predict inferior outcome in acute myeloid leukemia.Microarray-based analysis and clinical validation identify ubiquitin-conjugating enzyme E2E1 (UBE2E1) as a prognostic factor in acute myeloid leukemia.Pseudogene BMI1P1 expression as a novel predictor for acute myeloid leukemia development and prognosis.New insights into transcriptional and leukemogenic mechanisms of AML1-ETO and E2A fusion proteins.Identifying high-risk adult AML patients: epigenetic and genetic risk factors and their implications for therapy.Bone marrow fibrosis at diagnosis predicts survival for primary acute myeloid leukemia.lncRNA co-expression network model for the prognostic analysis of acute myeloid leukemia.Genetic variants involved in oxidative stress, base excision repair, DNA methylation, and folate metabolism pathways influence myeloid neoplasias susceptibility and prognosis.The prevalence and clinical profiles of FLT3-ITD, FLT3-TKD, NPM1, C-KIT, DNMT3A, and CEBPA mutations in a cohort of patients with de novo acute myeloid leukemia from southwest China.C59T mutation in exon 2 of monocytic leukemia-associated antigen-34 gene indicates a high risk of recurrence of acute myeloid leukemia.Regulation of Neuronal Survival by Nucleophosmin 1 (NPM1) Is Dependent on Its Expression Level, Subcellular Localization, and Oligomerization Status.Tumor SHB gene expression affects disease characteristics in human acute myeloid leukemia.SH3BGRL as a novel prognostic biomarker is down-regulated in acute myeloid leukemia.The Ins and Outs of Autophagy and Metabolism in Hematopoietic and Leukemic Stem Cells: Food for ThoughtBiological and clinical influences of in acute myeloid leukemia patients with mutations
P2860
Q26752430-F53B3F4A-1A3E-4DE3-B098-3D81D86EA7E4Q26752627-878F47B8-4A15-40A1-832D-8FAD8EF08C88Q33761979-845241F9-D6B7-4437-A1E4-C9EED79B23FCQ36585150-97C704F5-FCCD-49ED-88E0-78576BB2B4B8Q37422290-9AA47735-78FF-43C1-A9E1-1EFA8CACC375Q37565147-93E87503-ABFA-4B02-BD35-D839DFA0A41DQ37679748-453D1562-9BB6-40DB-9D80-C5C426BF3EDDQ38694866-A5489282-48BC-4519-8347-B082E68D1A0CQ38739162-9349D89F-0CB2-422E-A9E2-C7A3F1F3E12BQ38871451-C76D109F-6D69-4A53-81A5-F8602F9470A3Q39942266-EA4386DB-E14D-4BCA-BCED-0319BF14B5C6Q40202671-204D8593-0573-4F2F-8643-D2760C221438Q40978288-5F5A8766-A31B-4F54-83FB-CFDA144B7787Q41161869-A76573FE-EF43-4F57-B729-CFCC65C393A1Q47691232-03D78FC7-C972-44AD-BD0F-AA784AD67503Q47956417-098A63A2-1B4E-4A31-8021-88C2A3C29300Q57491369-9E073EE3-3F3D-4696-A65D-E16B1DE4D6E8Q58797413-ECC7E18C-B091-4261-9EAF-9484C5BC0D81
P2860
description
2015 nî lūn-bûn
@nan
2015 թուականին հրատարակուած գիտական յօդուած
@hyw
2015 թվականին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Molecular Genetic Markers in Acute Myeloid Leukemia
@ast
Molecular Genetic Markers in Acute Myeloid Leukemia
@en
Molecular Genetic Markers in Acute Myeloid Leukemia
@nl
type
label
Molecular Genetic Markers in Acute Myeloid Leukemia
@ast
Molecular Genetic Markers in Acute Myeloid Leukemia
@en
Molecular Genetic Markers in Acute Myeloid Leukemia
@nl
prefLabel
Molecular Genetic Markers in Acute Myeloid Leukemia
@ast
Molecular Genetic Markers in Acute Myeloid Leukemia
@en
Molecular Genetic Markers in Acute Myeloid Leukemia
@nl
P2860
P3181
P356
P1476
Molecular Genetic Markers in Acute Myeloid Leukemia
@en
P2093
Sophia Yohe
P2860
P304
P3181
P356
10.3390/JCM4030460
P407
P577
2015-01-01T00:00:00Z